Phase 1 NHL, Adult Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

SynKIR-310 for Relapsed/Refractory B-NHL

Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma+23 more

Verismo Therapeutics36 enrolled5 locationsNCT06544265

Recruiting

Phase 1

A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients

AML, Adult RecurrentNHL, Adult

Shengke Pharmaceuticals (Jiangsu) Limited, China60 enrolled2 locationsNCT05758610

Recruiting

Phase 1Phase 2

APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

NHL, Adult

Ascentage Pharma Group Inc.51 enrolled4 locationsNCT05186012